top of page

Mastering Effective Language in Pharma Meetings: Tips for Using Terminology and Fostering Inclusivity

  • 3 days ago
  • 3 min read

Clear communication plays a crucial role in pharmaceutical meetings. These gatherings often bring together diverse professionals—from researchers and regulatory experts to marketing teams and healthcare providers. Using language effectively in this environment ensures that ideas are understood, decisions are made efficiently, and collaboration thrives. This post explores how to use industry-specific terminology appropriately, avoid confusing jargon, and create an inclusive atmosphere that welcomes all voices.



Eye-level view of a conference room table with pharmaceutical documents and a laptop
Pharmaceutical meeting materials on a conference table


Understanding the Role of Language in Pharma Meetings


Pharmaceutical meetings often involve complex topics such as drug development, clinical trials, regulatory compliance, and market access. Each area has its own specialized vocabulary. Using the right terms helps convey expertise and precision. However, overusing technical language or jargon can alienate participants who may not share the same background.


Why language matters:


  • Clarity: Precise terms reduce misunderstandings.

  • Efficiency: Clear communication speeds up decision-making.

  • Respect: Using accessible language shows respect for all participants.

  • Collaboration: Inclusive language encourages diverse contributions.


Balancing technical accuracy with accessibility is key. This balance supports productive discussions and fosters a culture where everyone feels valued.



Using Industry-Specific Terminology Appropriately


Pharma professionals rely on terms like pharmacokinetics, adverse events, regulatory submission, and biologics. These words carry specific meanings and should be used carefully.



Tips for using terminology effectively:


  • Know your audience

Tailor your language to the group. For example, a meeting with clinical researchers can include detailed scientific terms. In contrast, a cross-functional meeting with marketing or finance teams may require simpler explanations.


  • Define terms when needed

When introducing specialized terms, briefly explain them. For example:

“Pharmacokinetics, which refers to how the body absorbs and processes a drug, is critical in determining dosage.”


  • Use terms consistently

Avoid switching between synonyms that might confuse listeners. Pick one term and stick with it throughout the discussion.


  • Avoid unnecessary jargon

Some phrases become jargon when overused or used without clear meaning. For example, instead of saying “move the needle,” say “improve outcomes.”


  • Provide examples

Illustrate complex terms with real-world examples. For instance, explain “adverse events” by describing a common side effect observed during a trial.



Avoiding Jargon That Creates Barriers


Jargon can exclude participants who are new to the field or come from different departments. It can also slow down meetings when people ask for clarifications.


Common pitfalls to avoid:


  • Overloading sentences with acronyms

Pharma is full of acronyms like FDA, EMA, NDA, and CRO. Spell out acronyms at least once and check if everyone understands them.


  • Using buzzwords without substance

Words like “synergy” or “robust” often add little meaning. Replace them with concrete descriptions.


  • Speaking too fast or assuming knowledge

Pause regularly to check for understanding and invite questions.



Strategies to reduce jargon:


  • Encourage a culture where asking for clarification is welcomed.

  • Use visual aids like charts or glossaries to support understanding.

  • Summarize key points in plain language at the end of discussions.





Inclusivity in language means making sure all participants feel comfortable and respected. This approach improves engagement and leads to better outcomes.


How to foster inclusivity:


  • Use gender-neutral language

Replace terms like “chairman” with “chairperson” or “team members” instead of “guys.”


  • Respect cultural differences

Avoid idioms or references that might confuse international colleagues.


  • Encourage diverse perspectives

Invite input from all attendees, especially those who may be less vocal.


  • Be mindful of tone

Use positive, supportive language rather than critical or dismissive remarks.


  • Avoid assumptions about expertise

Don’t assume everyone has the same background knowledge. Provide context when necessary.



More examples:


  • Instead of saying “Let’s circle back,” say “Let’s revisit this topic later.”

  • Use “people with diabetes” rather than “diabetics” to emphasize person-first language.




Here are actionable tips to improve language use and inclusivity in your next pharma meeting:


  • Prepare a glossary of key terms and acronyms for the meeting agenda.

  • Start meetings with a brief overview of technical terms relevant to the discussion.

  • Use clear and concise language; avoid long, complicated sentences.

  • Check in regularly with participants to ensure understanding.

  • Encourage questions and create a safe space for clarification.

  • Summarize decisions and next steps in plain language at the end.

  • Use visuals like slides or handouts to support verbal explanations.

  • Be aware of nonverbal cues that might indicate confusion or disengagement.




Instead of:

“We need to leverage our CRO’s robust capabilities to optimize patient recruitment and move the needle on enrollment.”


Say:

“Our contract research organization has strong experience in recruiting patients. We should work closely with them to improve enrollment numbers.”




Instead of:

“The NDA submission requires a deep dive into the pharmacovigilance data to ensure compliance.”


Say:

“The new drug application needs a thorough review of safety data to meet regulatory requirements.”




Instead of:

“Let’s circle back on the KPIs and ensure we have actionable insights for the launch.”


Say:

“We will review the key performance indicators again to make sure we have clear information for the product launch.”



 
 
 

Comments


bottom of page